Mangrove Partners’s Aimei Health Technology Right AFJKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-750,000
Closed -$270K – 155
2025
Q1
$270K Hold
750,000
– – 0.03% 137
2024
Q4
$135K Hold
750,000
– – 0.01% 144
2024
Q3
$172K Hold
750,000
– – 0.01% 142
2024
Q2
$158K Hold
750,000
– – 0.01% 125
2024
Q1
$150K Buy
+750,000
New +$148K 0.01% 143

Other funds holding AFJKR

Mangrove Partners's AFJKR Position: Q2 2025 in Review

Mangrove Partners sold out of Aimei Health Technology Right (AFJKR) in Q2 2025, closing a stake of 750,000 shares — an estimated $270K sold.

Mangrove Partners first reported a position in AFJKR in Q1 2024 and held it in 5 quarters. The position peaked at $270K in Q1 2025. 13 funds tracked by Wall St. Rank hold AFJKR as of Q2 2025.

  • Mangrove Partners reported no remaining Aimei Health Technology Right position as of Q2 2025 after selling out during the quarter.
  • Mangrove Partners sold 750,000 Aimei Health Technology Right shares in Q2 2025, an estimated $270K.
  • Mangrove Partners first reported a position in Aimei Health Technology Right in Q1 2024 and held it in 5 quarters.
  • Mangrove Partners's Aimei Health Technology Right position peaked at $270K in Q1 2025.
  • 13 funds tracked by Wall St. Rank held Aimei Health Technology Right as of Q2 2025.

Based on Mangrove Partners's 13F filing for Q2 2025, filed 14 Aug 2025.